Legend Biotech (LEGN) EBT (2019 - 2025)
Legend Biotech (LEGN) reported EBT of $19.6 million for Q4 2025, down 51.6% on a YoY basis from $40.5 million in Q4 2024, and up 150.16% quarter-over-quarter from -$39.1 million in Q3 2025.
Legend Biotech (LEGN) EBT (2019 - 2025) Analysis & Trends
Legend Biotech has reported EBT for 7 years, with the latest figure at $19.6 million in Q4 2025.
- For the quarter ending Q4 2025, EBT fell 51.6% year-over-year to $19.6 million; the trailing twelve-month figure through Dec 2025 stood at -$243.4 million (down 53.91% YoY), and the FY2025 full-year result was -$282.6 million, down 278.75% from the prior year.
- EBT for Q4 2025 stood at $19.6 million, up from -$39.1 million in the prior quarter.
- The five-year high for EBT was $40.5 million in Q4 2024, with the low at -$198.8 million in Q2 2023.
- Historically, EBT has averaged -$83.6 million across 5 years, with a median of -$90.0 million in 2021.
- Annual changes were most pronounced in 2022 — EBT slumped 33858.75% — and 2024, when it soared 127.59%.
- Legend Biotech's EBT stood at -$88.3 million in 2021, then sank by 53.65% to -$135.7 million in 2022, then dropped by 8.17% to -$146.8 million in 2023, then soared by 127.59% to $40.5 million in 2024, then slumped by 51.6% to $19.6 million in 2025.
- The last three EBT figures came in at $19.6 million (Q4 2025), -$39.1 million (Q3 2025), and -$124.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 831.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.60 Mn |
| Sep 30, 2025 | -39.07 Mn |
| Jun 30, 2025 | -124.80 Mn |
| Mar 31, 2025 | -99.13 Mn |
| Dec 31, 2024 | 40.50 Mn |
| Sep 30, 2024 | -120.89 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Mar 31, 2024 | -59.79 Mn |
| Dec 31, 2023 | -146.81 Mn |
| Sep 30, 2023 | -62.50 Mn |
| Jun 30, 2023 | -198.84 Mn |
| Mar 31, 2023 | -111.97 Mn |
| Dec 31, 2022 | -135.72 Mn |
| Sep 30, 2022 | -84.80 Mn |
| Jun 30, 2022 | -193.07 Mn |
| Mar 31, 2022 | -32.13 Mn |
| Dec 31, 2021 | -88.33 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -91.58 Mn |
| Mar 31, 2021 | -94,603.00 |